Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.33 |
| ▸ | CD38 | P28907 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21725684 | 1.00 | SMYD3 (0.33) | SMYD3CD38EPHX2 | |
| SCHEMBL22764118 | 0.90 | SMYD3 (0.34) | SMYD3CD38 | |
| SCHEMBL22764075 | 0.90 | SMYD3 (0.34) | SMYD3CD38 | |
| SCHEMBL19663472 | 0.80 | — | — | |
| SCHEMBL14706852 | 0.76 | SMYD3 (0.35) | SMYD3EPHX2 | |
| SCHEMBL20327540 | 0.76 | SMYD3 (0.35) | SMYD3EPHX2 | |
| SCHEMBL20327699 | 0.76 | SMYD3 (0.35) | SMYD3EPHX2 | |
| SCHEMBL13190992 | 0.74 | NPC1 (0.47) | EPHX2 | |
| SCHEMBL3349569 | 0.74 | NPC1 (0.47) | EPHX2 | |
| SCHEMBL4919308 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10562893-B2 | Benzimidazoles derivatives as Tec kinases family inhibitors | GB005, INC. (US) | 2020-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10562893-B2 | Benzimidazoles derivatives as Tec kinases family inhibitors | BMX, TEC, BTK | SMYD3 3337/4885CD38 2647/4885EPHX2 848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.